PCSK9 and cardiovascular disorder: Recently, Trinder et al. (5) showed that monogenic (LDL receptor, apolipoprotein B and PCSK9) and polygenic hypercholesterolemia were associated with an increased risk of atherosclerotic cardiovascular disease events compared with the general population.